Indrayani Biotech appoints secretarial auditor and accepts CS resignation

Indrayani Biotech Limited has announced the appointment of Ms. Nattery Srinivasan Poornima as its Secretarial Auditor for the Financial Year 2025-26. This appointment follows the resignation of the previous auditor, Mr. K. Ravichandran. Additionally, the company has accepted the resignation of Mr. C.S. Shanmuga Sundar from the positions of Company Secretary and Compliance Officer, effective November 02, 2026, due to personal reasons.

Indrayani Biotech Announces Key Appointments and Resignations

Indrayani Biotech Limited has made significant changes in its corporate governance structure. The company’s Board of Directors, in a meeting held on November 02, 2026, approved the appointment of Ms. Nattery Srinivasan Poornima as the new Secretarial Auditor. Ms. Poornima, a Company Secretary in Practice (CP No.: 24073), will serve for the Financial Year 2025-26, filling a casual vacancy caused by the resignation of Mr. K. Ravichandran.

Changes in Company Secretary Role

In a separate development, the Board has accepted the resignation of Mr. C.S. Shanmuga Sundar from his roles as Company Secretary and Compliance Officer. Mr. Sundar submitted his resignation on September 17, 2026. Following the mandatory 45-day notice period as per company policy, his resignation is effective from the close of business hours on November 02, 2026. The reason cited for his departure is personal.

Brief Profile of New Secretarial Auditor

Ms. Nattery Srinivasan Poornima is described as a Corporate Strategist, Transaction Advisor, and Governance Professional with extensive expertise in M&A, foreign investments, business structuring, regulatory advisory, and board governance. Her profile highlights a deep understanding of corporate laws, securities laws, FEMA, and other regulatory frameworks. She also serves as an Independent Director on the board of a listed company and is involved in academia.

Source: BSE

Previous Article

Relic Technologies reports Q2 FY27 results with standalone profit of ₹24.26 crore

Next Article

Akums reports 32% revenue growth and 106% EBITDA growth in Q2 FY27